SELECT LANGUAGE BELOW

Trump’s GLP-1 Initiative Might Help Novo Nordisk and Eli Lilly

Trump's GLP-1 Initiative Might Help Novo Nordisk and Eli Lilly

Concerns in the Pharmaceutical Sector Amid Tariff Threats This week, a significant concern arose for drugmakers as President Trump proposed implementing tariffs of up to 250% on imported medications. This news has unsettled the healthcare industry, leading to a 2.74% decline over the past five days, contributing to an overall drop of 5.13% this year. […]

Real-world outcomes of GLP-1 treatments do not meet clinical trial results when compared to surgery.

Real-world outcomes of GLP-1 treatments do not meet clinical trial results when compared to surgery.

Weight Loss Surgery Outperforms GLP-1 Injections A recent study revealed that weight loss surgery is significantly more effective—about five times more—than weekly injections of popular GLP-1 receptor agonists such as semaglutide (like Ozempic) and tilzepatide (like Mounjaro). This finding was shared during the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Science Conference held […]

RFK Jr. Explores Bold New Framework for Medicaid and Medicare Coverage of GLP-1 Medications!

RFK Jr. considering 'framework' for Medicaid, Medicare coverage of GLP-1s

Health and Human Services (HHS) Director Robert F. Kennedy Jr. mentioned he is contemplating a Medicare and Medicaid “regulatory framework” that encompasses GLP-1 medications for obesity treatment. Kennedy noted in a CBS News Interview that the primary obstacle for coverage is the high price of the medication, but indicated that Medicaid and Medicare are looking […]

FDA approves GLP-1 generic for Type 2 diabetes

The U.S. Food and Drug Administration (FDA) Generic daily injection approved GLP-1 treatment for type 2 diabetes patients aged 10 years and older. Currently in short supply, liraglutide injection, sold under the brand name Victoza, will provide a low-cost option for people in need of a GLP-1 treatment. “Generic drugs provide additional treatment options that […]

Diabetes patients have access to first generic GLP-1 medication: ‘More accessible’

Ozempic, Wegovy and other GLP-1 drugs have been shown to reduce weight and Diabetes Management Demand has skyrocketed in recent years, making it difficult for some people to obtain the medicine. To clear up supply chain disruptions, the first-ever generic GLP-1, a replica of Victoza, was launched on June 25th. Victoza, manufactured by Novo Nordisk […]

Ozempic and other GLP-1 drugs could reduce arthritis symptoms in some, experts claim

Ozempic used to treat arthritis pain: report Fox News medical commentator Dr. Marc Siegel appeared on “Fox & Friends” to discuss his views on Ozempic’s use to treat arthritis pain and why some doctors are warning that some medications may affect heat sensitivity. Popular Drugs Weight loss Some anecdotal reports suggest that diabetes control may […]